Walking Fish Therapeutics has closed after a lead investor backed out of a critical series B round.
CEO Rusty Williams, M.D., Ph.D., said in an interview with Fierce Biotech that the biotech was on the precipice of securing fresh capital to enter the clinic when an unnamed top investor…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
